Physician profile
Beth Patel
NPI 1528383296
$5,063.84
in general payments reported to CMS, 2019-2025
38 companies · $667 in 2025
The $667 reported for 2025 was more than what 80% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,132 · 2022: $1,005 · 2023: $989 · 2024: $1,271 · 2025: $667.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,909 · Education: $17.38.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,909.48 |
| Education | $17.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $870.09 | 2021-2025 | |
| Novo Nordisk INC | $777.72 | 2021-2025 | Rybelsus, Ozempic, Wegovy |
| Amgen INC. | $706.13 | 2021-2025 | Repatha, Otezla, Evenity |
| Pfizer INC. | $400.65 | 2021-2025 | |
| Phathom Pharmaceuticals, INC. | $340.96 | 2024 | Voquezna |
| Lilly USA, LLC | $241.65 | 2021-2024 | Mounjaro |
| Bayer Healthcare Pharmaceuticals INC. | $175.43 | 2021-2025 | |
| Exact Sciences Corporation | $149.21 | 2023-2025 | Cologuard Collection Kit |
| Abbott Laboratories | $120.26 | 2021-2025 | Freestyle Libre 3, Id Now Instrument |
| Boston Scientific Corporation | $114.95 | 2021-2025 | Watchman Flx |
| Astrazeneca Pharmaceuticals Lp | $109.57 | 2022-2024 | Airsupra, Evusheld |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $99.12 | 2021-2023 | Xifaxan |
| Axsome Therapeutics, INC. | $94.41 | 2025 | Auvelity |
| Novartis Pharmaceuticals Corporation | $89.84 | 2021-2023 | |
| Glaxosmithkline, LLC. | $86.12 | 2021-2023 | Trelegy Ellipta |
Show all 38 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Beth Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.